Aster Capital Management (Difc) LTD Cytokinetics Inc Transaction History
Aster Capital Management (Difc) LTD
- $198 Billion
- Q3 2025
A detailed history of Aster Capital Management (Difc) LTD transactions in Cytokinetics Inc stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 811 shares of CYTK stock, worth $53,136. This represents 0.02% of its overall portfolio holdings.
Number of Shares
811Holding current value
$53,136% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
411Shares Held
128MCall Options Held
3.79MPut Options Held
1.13M-
T. Rowe Price Investment Management, Inc. Baltimore, MD19.1MShares$1.25 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$961 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$777 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.41MShares$485 Million0.07% of portfolio
-
State Street Corp Boston, MA5.62MShares$368 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $6.17B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...